Functional consequences of ATM sequence variants for chromosomal radiosensitivity

Sara Gutiérrez-Enríquez1, Marie Fernet, Thilo Dörk

  • 1DNA Repair Group, International Agency for Research on Cancer, Lyon, France.

Insights

Specific ATM gene alterations, including heterozygous mutations and variant alleles, increase in vitro chromosomal radiosensitivity. This suggests ATM gene variants may impact DNA repair and cellular response to radiation.

Area of Science:

  • Genetics
  • Molecular Biology
  • Cancer Research

Background:

  • The ATM (ataxia-telangiectasia mutated) protein is crucial for DNA double-strand break repair.
  • The link between ATM gene single-nucleotide polymorphisms (SNPs) and cancer risk or radiosensitivity requires further investigation.

Purpose of the Study:

  • To investigate the functional impact of specific ATM SNPs on in vitro radiosensitivity.
  • To assess radiosensitivity using micronuclei (MN) formation in lymphoblastoid cell lines.

Main Methods:

  • Lymphoblastoid cell lines from breast cancer (BC) patients, ataxia-telangiectasia (A-T) patients, A-T heterozygotes (A-T het), and normal individuals were used.
  • Cells were exposed to ionizing radiation (IR), and MN formation was quantified.
  • Specific ATM SNPs, including 2572T>C and 3161C>G, were analyzed in BC cell lines.

Main Results:

  • BC, A-T het, and A-T cell lines exhibited significantly higher MN formation post-IR compared to normal cell lines.
  • The linked 2572T>C and 3161C>G variants in BC lines were associated with increased MN formation.
  • Elevated MN levels were independent of constitutive ATM mRNA levels in these cell lines.

Conclusions:

  • Alterations in the ATM gene, including heterozygous mutations and specific variant alleles (2572C, 3161G), are linked to increased in vitro chromosomal radiosensitivity.
  • These ATM variants may impair DNA repair by interfering with ATM protein function, potentially in a dominant-negative manner.

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Mutations01:35

Mutations

Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Mutations01:39

Mutations

Overview
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Mismatch Repair01:20

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...